Literature DB >> 3978785

Total cholinesterase in plasma: biological variations and reference limits.

L Lepage, F Schiele, R Gueguen, G Siest.   

Abstract

Factors affecting biological variation in total cholinesterase activity in plasma were studied in a population of 3372 apparently healthy subjects at least four years old. Determination of the dibucaine number, after inhibition of the activity by dibucaine, made it possible to specify the contributions of genetic and physiological characteristics to variations in the total activities by using a statistical method of segmentation. The main factors modifying plasma cholinesterase activity in males are genetic status (dibucaine number) and degree of overweight (subscapular skinfold). In females, hormonal status (puberty or menopause), genetic status (dibucaine number), and the use of oral contraceptives are the factors mainly responsible for the variations of plasma cholinesterase activity. These data allow us to propose reference limits for total plasma cholinesterase.

Entities:  

Keywords:  Age Factors; Biology; Clinical Research; Contraception; Contraceptive Agents, Female; Demographic Factors; Family Planning; Genetics; Oral Contraceptives; Population; Population Characteristics; Research Methodology; Sex Factors

Mesh:

Substances:

Year:  1985        PMID: 3978785

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  10 in total

1.  Determinants of butyrylcholinesterase inhibition among agricultural pesticide handlers in Washington State: an update.

Authors:  Jennifer E Krenz; Jonathan N Hofmann; Theresa R Smith; Rad N Cunningham; Richard A Fenske; Christopher D Simpson; Matthew Keifer
Journal:  Ann Occup Hyg       Date:  2014-09-26

Review 2.  Protein adducts as biomarkers of exposure to organophosphorus compounds.

Authors:  Judit Marsillach; Lucio G Costa; Clement E Furlong
Journal:  Toxicology       Date:  2012-12-20       Impact factor: 4.221

3.  Factors affecting inter-individual variation in human plasma cholinesterase activity: body weight, height, sex, genetic polymorphism and age.

Authors:  A Brock; V Brock
Journal:  Arch Environ Contam Toxicol       Date:  1993-01       Impact factor: 2.804

4.  [Assessment of nutritional status--a part of routine clinical diagnosis: cholinesterase activity as a nutritional indicator].

Authors:  G Ollenschläger; M Schrappe-Bächer; M Steffen; B Bürger; B Allolio
Journal:  Klin Wochenschr       Date:  1989-11-03

5.  Is organic farming safer to farmers' health? A comparison between organic and traditional farming.

Authors:  Carla Costa; Julia García-Lestón; Solange Costa; Patrícia Coelho; Susana Silva; Marta Pingarilho; Vanessa Valdiglesias; Francesca Mattei; Valentina Dall'Armi; Stefano Bonassi; Blanca Laffon; John Snawder; João Paulo Teixeira
Journal:  Toxicol Lett       Date:  2014-02-24       Impact factor: 4.372

6.  Inter and intraindividual variations in plasma cholinesterase activity and substance concentration in employees of an organophosphorus insecticide factory.

Authors:  A Brock
Journal:  Br J Ind Med       Date:  1991-08

7.  The effect of age and frailty upon blood esterase activities and their response to dietary supplementation.

Authors:  J Summerbell; H Wynne; C R Hankey; F M Williams
Journal:  Br J Clin Pharmacol       Date:  1993-11       Impact factor: 4.335

8.  Butyrylcholinesterase genotype and enzyme activity in relation to Gulf War illness: preliminary evidence of gene-exposure interaction from a case-control study of 1991 Gulf War veterans.

Authors:  Lea Steele; Oksana Lockridge; Mary M Gerkovich; Mary R Cook; Antonio Sastre
Journal:  Environ Health       Date:  2015-01-09       Impact factor: 5.984

9.  Prolonged neuromuscular block associated with cholinesterase deficiency.

Authors:  Chao Zhang; Hui Cao; Zhi Gang Wan; Jie Wang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

10.  Cholinesterase alterations in delirium after cardiosurgery: a German monocentric prospective study.

Authors:  Elisabeth Hannah Adam; Victoria Haas; Simone Lindau; Kai Zacharowski; Bertram Scheller
Journal:  BMJ Open       Date:  2020-01-14       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.